Differential effects of diet-induced dyslipidemia and hyperglycemia on mesenteric resistance artery structure and function in type 2 diabetes

Journal of Pharmacology and Experimental Therapeutics

Volumn 328, Issue 1, 2009, Pages 123-130

  Sachidanandam, Kamakshi ^a   Hutchinson, Jim R ^b   Elgebaly, Mostafa M ^a   Mezzetti, Erin M ^b   Wang, Mong Heng ^b   Ergul, Adviye ^a,b  

^a UNIVERSITY OF GEORGIA   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALPHA ACTININ; CALPONIN; COLLAGEN; COLLAGENASE 3; ENDOTHELIN 1; GELATINASE A; GELATINASE B; HEMOGLOBIN A1C; MATRIX METALLOPROTEINASE; NITROPRUSSIDE SODIUM;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DYSLIPIDEMIA; ENZYME ACTIVITY; GOTO KAKIZAKI RAT; HYPERGLYCEMIA; HYPERINSULINEMIA; IMMUNOBLOTTING; INSULIN RESISTANCE; LIPID DIET; MESENTERIC ARTERY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASOCONSTRICTION; VASODILATATION; WEIGHT GAIN; WISTAR RAT; ANGIOGRAPHY; ANIMAL; CHEMICALLY INDUCED DISORDER; DIABETIC ANGIOPATHY; DISEASE MODEL; DRUG EFFECT; FAT INTAKE; HUMAN; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; VASCULAR RESISTANCE;

ACETYLCHOLINE; ANGIOGRAPHY; ANIMALS; COLLAGEN; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIETARY FATS; DISEASE MODELS, ANIMAL; DYSLIPIDEMIAS; HUMANS; HYPERGLYCEMIA; MALE; MATRIX METALLOPROTEINASES; MESENTERIC ARTERIES; NITROPRUSSIDE; RATS; RATS, WISTAR; RISK FACTORS; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATION;

EID: 59149094001     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.142612     Document Type: Article

References (39)

1. Amiri F, Virdis A, Neves MF, Iglarz M, Seidah NG, Touyz RM, Reudelhuber TL, and Schiffrin EL (2004) Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction. Circulation 110:2233-2240.
2. Bhattacharya I, Mundy AL, Widmer CC, Kretz M, and Barton M (2008) Regional heterogeneity of functional changes in conduit arteries after high-fat diet. Obesity 16:743-748.
3. Bourgoin F, Bachelard H, Badeau M, Mélançon S, Pitre M, Larivière R, and Nadeau A (2008) Endothelial and vascular dysfunctions and insulin resistance in rats fed a high fat high sucrose diet. Am J Physiol Heart Circ Physiol 295:H1044-H1055.
4. Bouvet C, Belin de Chantemèle E, Guihot AL, Vessières E, Bocquet A, Dumont O, Jardel A, Loufrani L, Moreau P, and Henrion D (2007) Flow-induced remodeling in resistance arteries from obese Zucker rats is associated with endothelial dysfunction. Hypertension 50:248-254.
5. Brondum E, Nilsson H, and Aalkjaer C (2005) Functional abnormalities in isolated arteries from Goto-Kakizaki and streptozotocin-treated diabetic rat models. Horm Metab Res 37 (Suppl 1):56-60.
6. Cheng ZJ, Vaskonen T, Tikkanen I, Nurminen K, Ruskoaho H, Vapaatalo H, Muller D, Park JK, Luft FC, and Mervaala EM (2001) Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats. Hypertension 37:433-439.
7. Cooper ME, Gilbert RE, and Jerums G (1997) Diabetic vascular complications. Clin Exp Pharmacol Physiol 24:770-775.
8. Cooper ME, Rumble J, Komers R, Du HC, Jandeleit K, and Chou ST (1994) Diabetes-associated mesenteric vascular hypertrophy is attenuated by angiotensin- converting enzyme inhibition. Diabetes 43:1221-1228.
9. Coulson RJ, Chesler NC, Vitullo L, and Cipolla MJ (2002) Effects of ischemia and myogenic activity on active and passive mechanical properties of rat cerebral arteries. Am J Physiol Heart Circ Physiol 283:H2268-H2275.
10. Edvinsson L, Nilsson E, and Jansen-Olesen I (2007) Inhibitory effect of BIBN4096BS, CGRP(8-37), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery. Br J Pharmacol 150:633-640.
11. Elgebaly MM, Kelly A, Harris AK, Elewa H, Portik-Dobos V, Ketsawatsomkron P, Marrero M, and Ergul A (2008) Impaired insulin-mediated vasorelaxation in a nonobese model of type 2 diabetes: role of endothelin-1. Can J Physiol Pharmacol 86:358-364.
12. Elgebaly MM, Portik-Dobos V, Sachidanandam K, Rychly D, Malcom D, Johnson MH, and Ergul A (2007) Differential effects of ET(A) and ET(B) receptor antagonism on oxidative stress in type 2 diabetes. Vascul Pharmacol 47:125-130.
13. Frisbee JC (2003) Remodeling of the skeletal muscle microcirculation increases resistance to perfusion in obese Zucker rats. Am J Physiol Heart Circ Physiol 285:H104-H111.
14. Ha TS (2006) High glucose and advanced glycosylated end-products affect the expression ofalpha-actinin-4 in glomerular epithelial cells. Nephrology 11:435-441.
15. Harris AK, Elgebaly MM, Li W, Sachidanandam K, and Ergul A (2008) Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes. Am J Physiol Regul Integr Comp Physiol 294:R1213-R1219.
16. Harris AK, Hutchinson JR, Sachidanandam K, Johnson MH, Dorrance AM, Stepp DW, Fagan SC, and Ergul A (2005) Type 2 diabetes causes remodeling of cerebro- vasculature via differential regulation of matrix metalloproteinases and collagen synthesis: role of endothelin-1. Diabetes 54:2638-2644.
17. Intengan HD and Schiffrin EL (1998) Mechanical properties of mesenteric resistance arteries from Dahl salt-resistant and salt-sensitive rats: role of endothelin-1. J Hypertens 16:1907-1912.
18. Johnson JL, van Eys GJ, Angelini GD, and George SJ (2001) Injury induces dedif- ferentiation of smooth muscle cells and increased matrix-degrading metallopro- teinase activity in human saphenous vein. Arterioscler Thromb Vasc Biol 21:1146 -1151.
19. Katakam PV, Pollock JS, Pollock DM, Ujhelyi MR, and Miller AW (2001) Enhanced endothelin-1 response and receptor expression in small mesenteric arteries of insulin-resistant rats. Am J Physiol Heart Circ Physiol 280:H522-H527.
20. 2+ and growth signals. Acta Physiol Scand 173:175-184.
21. Lucchesi PA, Sabri A, Belmadani S, and Matrougui K (2004) Involvement of metal- loproteinases 2/9 in epidermal growth factor receptor transactivation in pressure-induced myogenic tone in mouse mesenteric resistance arteries. Circulation 110: 3587-3593.
22. Miller AW, Tulbert C, Puskar M, and Busija DW (2002) Enhanced endothelin activity prevents vasodilation to insulin in insulin resistance. Hypertension 40: 78-82.
23. Molnar J, Yu S, Mzhavia N, Pau C, Chereshnev I, and Dansky HM (2005) Diabetes induces endothelial dysfunction but does not increase neointimal formation in high-fat diet fed C57BL/6J mice. Circ Res 96:1178-1184.
24. Muhammad S (2004) Epidemiology of diabetes and obesity in the United States. Compend Contin Educ Dent 25:195-198, 200, 202; quiz 204.
25. Mundy AL, Haas E, Bhattacharya I, Widmer CC, Kretz M, Hofmann-Lehmann R, Minotti R, and Barton M (2007) Fat intake modifies vascular responsiveness and receptor expression of vasoconstrictors: implications for diet-induced obesity. Cardiovasc Res 73:368-375.
26. Nagase H and Woessner JF Jr (1999) Matrix metalloproteinases. J Biol Chem 274:21491-21494.
27. Rigsby CS, Burch AE, Ogbi S, Pollock DM, and Dorrance AM (2007) Intact female stroke-prone hypertensive rats lack responsiveness to mineralocorticoid receptor antagonists. Am J Physiol Regul Integr Comp Physiol 293:R1754-R1763.
28. Sachidanandam K, Elgebaly MM, Harris AK, Hutchinson JR, Mezzetti EM, Portik-Dobos V, and Ergul A (2008) Effect of chronic and selective endothelin receptor antagonism on microvascular function in type 2 diabetes. Am JPhysiol HeartCirc Physiol 294:H2743-H2749.
29. Sachidanandam K, Harris A, Hutchinson J, and Ergul A (2006) Microvascular versus macrovascular dysfunction in type 2 diabetes: differences in contractile responses to endothelin-1. Exp Biol Med (Maywood) 231:1016-1021.
30. Sachidanandam K, Portik-Dobos V, Harris AK, Hutchinson JR, Muller E, Johnson MH, and Ergul A (2007) Evidence for vasculoprotective effects ofETB receptors in resistance artery remodeling in diabetes. Diabetes 56:2753-2758.
31. Said N and Motamed K (2005) Absence of host-secreted protein acidic and rich in cysteine (SPARC) augments peritoneal ovarian carcinomatosis. Am J Pathol 167: 1739-1752.
32. Schaafsma D, McNeill KD, Stelmack GL, Gosens R, Baarsma HA, Dekkers BG, Frohwerk E, Penninks JM, Sharma P, Ens KM, et al. (2007) Insulin increases the expression of contractile phenotypic markers in airway smooth muscle. Am J Physiol Cell Physiol 293:C429-C439.
33. Schafer K, Halle M, Goeschen C, Dellas C, Pynn M, Loskutoff DJ, and Konstantin- ides S (2004) Leptin promotes vascular remodeling and neointimal growth in mice. Arterioscler Thromb Vasc Biol 24:112-117.
34. Shah BH and Catt KJ (2003) A central role of EGF receptor transactivation in angiotensin II -induced cardiac hypertrophy. Trends Pharmacol Sci 24:239 -244.
35. StandaertML, SajanMP, Miura A, KanohY, ChenHC, Farese RVJr, and FareseRV (2004) Insulin-induced activation of atypical protein kinase C, but not protein kinase B, is maintained in diabetic (ob/ob and Goto-Kakazaki) liver: contrasting insulin signaling patterns in liver versus muscle define phenotypes of type 2 diabetic and high fat-induced insulin-resistant states. J Biol Chem 279:24929-24934.
36. Stepp DW, Pollock DM, and Frisbee JC (2004) Low-flow vascular remodeling in the metabolic syndrome X. Am J Physiol Heart Circ Physiol 286:H964-H970.
37. Visse R and Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92:827-839.
38. Wang MH, Smith A, Zhou Y, Chang HH, Lin S, Zhao X, Imig JD, and Dorrance AM (2003) Downregulation of renal CYP-derived eicosanoid synthesis in rats with diet-induced hypertension. Hypertension 42:594-599.
39. Zhou Y, Lin S, Chang HH, Du J, Dong Z, Dorrance AM, Brands MW, and Wang MH (2005) Gender differences of renal CYP-derived eicosanoid synthesis in rats fed a high-fat diet. Am JHypertens 18:530-537.